Sfoglia per AUTORE
CALCAGNO A
Collezione ASL Città di Torino
Items : 133
Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group. in Infection / Infection. 2024 Sep 20. doi: 10.1007/s15010-024-02390-y.
2024
ASL Asti
ASL Città di Torino
Aliberti S; Codecasa L; Blasi F; Gori A; Spotti M; Cinnirella G; Venuti F; Lupia T; Gaviraghi A; Calcagno A; Stroffolini G;
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Trentalange A; Giaccone C; Trunfio M; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Vai D; Lazzaro A;
Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation. in The Journal of clinical investigation / J Clin Invest. 2024 Oct 1;134(19):e176358. doi: 10.1172/JCI176358.
2024
ASL Città di Torino
Price RW; Cinque P; Gisslen M; Spudich S; Vercesi R; Zhou S; Calcagno A; Trunfio M; Dravid A; Kincer LP; Joseph SB;
Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.
2024
ASL Città di Torino
Gulminetti R; Ripamonti D; Antinori A; Muscatello A; Gabrieli A; Bruzzesi E; Rusconi S; Marchetti G; Bernasconi D; Trunfio M; Cinque P; Cusato J; Antonucci M; Calcagno A; Nozza S;
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino
Vai D; Bonora S; Di Perri G; Calcagno A; Letendre SL; Cinnirella G; Imperiale D; Quarta C; Trunfio M; Vuaran E; Di Stefano A;
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Letendre SL; Calcagno A; Di Perri G; Cavallo R; Bonora S; Imperiale D; Croce M; Pittaluga F; Vai D; Trunfio M; Sacchi A;
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; D'Avolio A; Di Perri G; Trunfio M; Marinaro L; Bonora S; Avataneo V; Mula J; Antonucci M; Cusato J; Manca A; Palermiti A;
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine. in Infection / Infection. 2024 Jun;52(3):737-765. doi: 10.1007/s15010-024-02183-3. Epub 2024 Feb 8.
2024
ASL Città di Torino
Goletti D; Schiuma M; Lapadula G; Mencarini J; Palmieri F; Gori A; Surace L; Falbo E; Pontali E; Russo A; Gualano G; Di Biagio A; Pirriatore V; Riccardi N; Trezzi M; Matteelli A; Coppola N; Sarmati L; Parrella R; Tadolini M; Calcagno A;
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino
Calcagno A; D'Avolio A; Ponzetta L; Marinaro L; Alladio F; Cat Genova E; Quaranta M; Stroffolini G; Gaviraghi A; de Nicolò A; Venuti F;
Central Nervous System Disorders with Auto-Antibodies in People Living with HIV. in Microorganisms / Microorganisms. 2024 Aug 24;12(9):1758. doi: 10.3390/microorganisms12091758.
2024
ASL Città di Torino
Calcagno A; Trunfio M; Di Perri G; Imperiale D; Stroffolini G; Atzori C;
A noma case report: A warning message from Northern Uganda. in Tropical medicine & international health : TM & IH / Trop Med Int Health. 2024 Aug;29(8):752-755. doi: 10.1111/tmi.14025. Epub 2024 Jun 30.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; Orlotti C; Montrucchio G; Ribero S; Achana B; Longo BM; Smart Okot G; Okao M; Merli M;
Doxycycline Post-exposure Prophylaxis and Sexually Transmitted Infections in Italy, 2023. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2024 Apr 24:ciae219. doi: 10.1093/cid/ciae219.
2024
ASL Città di Torino
Lucchini A; Ghisetti V; Delmonte S; Agosta D; Del Re S; Calcagno A; Tutone M;
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.
2023
ASL Città di Torino
ASL Asti
Bonora S; Calcagno A; Frascione PMM; De Rosa FG; Gregorc V; Pepe A; Ponzetta L; Vita D; Allice T; Lupia T; Ranzani FA; Venuti F; Gaviraghi A; Longo BM;
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.
2023
ASL Città di Torino
ASL Asti
Penna D; Piccioni P; Venuti F; Botto C; Trezzi M; Betti M; Sestini S; Erba PA; Lupia T; Di Perri G; Aliberti S; Calcagno A; Stroffolini G; Gaviraghi A;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; Bonora S; Di Perri G; Maiese D; Ferrara M; Antonucci M; Chiara F; De Vivo ED; Costanzo M; Cusato J; Manca A; Mula J; Palermiti A;
COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; De Rosa FG; Di Perri G; Ferrara M; De Vivo ED; Ianniello A; Chiara F; Corcione S; Antonucci M; Trunfio M; Costanzo M; Palermiti A; Mula J; Cusato J; Manca A;
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino
Bonora S; Calcagno A; Alladio F; Fantino S; Di Perri G; Burdino E; Allice T; Longo BM; Di Girolamo L; Ferrara M; Trevisan G;
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino
Di Perri G; Bonora S; Guastamacchia G; Nigra M; Napoli L; Atzori C; Trunfio M; Mighetto L; Calcagno A;
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.
2023
ASL Città di Torino
Bonora S; Calcagno A; Marchiaro C; D'Avolio A; Cinnirella G; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Stroffolini G; Gaviraghi A; Longo BM; De Nicolò A; Venuti F;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
Mula J; Bonora S; D'Avolio A; Calcagno A; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Cusato J; Avataneo V; Antonucci M;
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV. in Journal of neurovirology / J Neurovirol. 2023 Feb;29(1):100-105. doi: 10.1007/s13365-022-01105-z. Epub 2022 Nov 9.
2023
ASL Città di Torino
Calcagno A; Di Perri G; Atzori C; Russo M; Burdino E; Imperiale D; Ponzetta L; Trunfio M; Di Girolamo L;
The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.
2023
ASL Città di Torino
Lembo D; Civra A; Radin M; Roccatello D; Trunfio M; Calcagno A; Arbrile M; Sciascia S;
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino
Calcagno A; Atzori C; Trunfio M; Di Perri G G; Bonora S; Barco A; Pirriatore V; Nigra M; Giaccone C; Vai D; Stroffolini G; Lazzaro A;
The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis. in Journal of medical virology / J Med Virol. 2023 Apr;95(4):e28704. doi: 10.1002/jmv.28704.
2023
ASL Città di Torino
Antinori A; Bonora S; Ghisetti V; D'Arminio Monforte A; Focà E; Vera JH; D'Ettorre G; Arsuffi S; Celani L; Bai F; Pinnetti C; Trunfio M; Calcagno A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants in Diagnostics
2023
ASL Città di Torino
Palermiti A; Manca A; Di Perri G; Mula J; Bonora S; D’Avolio A; Calcagno A; Cusato J; Avataneo V; Antonucci M; Trunfio M; Marinaro L;
NEUROCOGNITIVE IMPAIRMENT NEGATIVELY AFFECTS VIRAL CONTROL IN ART-TREATED PWH in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Vuaran E; Vai D; Di Stefano A; Imperiale D; Bonora S; Di Perri G; Calcagno A;
THE CEREBROSPINAL FLUID VIROME IN VIRALLY SUPPRESSED PEOPLE LIVING WITH HIV in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Fox V; Scutari R; Fini V; Granaglia A; Russo C; Vuaran E; Imperiale D; Perno CF; Bonora S; Di Perri G; Alteri C; Calcagno A;
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia. in Lung / Lung. 2022 Oct;200(5):573-577. doi: 10.1007/s00408-022-00566-7. Epub 2022 Sep 17.
2022
ASL Città di Torino
Bonora S; Di Perri G; Trunfio M; Cortese G; Traverso F; Nespoli P; Vicinanza S; Portesani F; Calcagno A;
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. in BMC infectious diseases / BMC Infect Dis. 2022 Nov 22;22(1):879. doi: 10.1186/s12879-022-07716-5.
2022
ASL Torino 3
ASL Torino 5
AO Ordine Mauriziano
ASL Alessandria
ASL Torino 4
ASL Città di Torino
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
ASL VCO
ASL Asti
ASL Novara
ASL Cuneo 2
AOU San Luigi di Orbassano
Scozzari G; Mitola B; Benedetti V; Danielle F; Libanore V; Blangetti I; Aldieri C; Converso M; Calcagno A; Bergamo D; Berti P; Pittaluga F; Avolio M; Costa C; Raso S; Chinaglia A; Vitale F; Liccardi MM; Canta F; Russo ML; Tornello A; Maddalena L; Delios G; Baldassano S; Mattei A; De Micheli AG; Marletto FP; Russo A; Nucci A; et alii...
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 3
Di Perri G; Calleri G; Calcagno A; Bonora S; Lipani F; Paltrinieri G; Lupia T; Faraoni S; Stroffolini G; Rossi L;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
Calcagno A; Rosa FG; Di Perri G; Chiara F; Antonucci M; De Nicolò A; Allegra S; De Francia S; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;
Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Imperiale D; Domini S; Alcantarini C; Trunfio M; Milesi M; Medina C; Vai D; De Francesco D;
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient. in International journal of STD & AIDS / Int J STD AIDS. 2022 Jan;33(1):94-96. doi: 10.1177/09564624211048343. Epub 2021 Oct 11.
2022
ASL Città di Torino
Trunfio M; Parietti M; Delmonte S; Conti L; Trentalange A; Bonora S; Calcagno A; Ribero S;
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic Study. in Molecules (Basel, Switzerland) / Molecules. 2022 Feb 3;27(3):1042. doi: 10.3390/molecules27031042.
2022
ASL Città di Torino
Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. in Annals of work exposures and health / Ann Work Expo Health. 2022 Feb 18;66(2):224-232. doi: 10.1093/annweh/wxab062.
2022
ASL Vercelli
ASL Città di Torino
Faggiano F; Vineis P; Patrucco F; Trunfio M; Gallo L; Locana E; Valinotto R; Di Perri G; Calcagno A; Airoldi C;
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. in The Lancet. Respiratory medicine / Lancet Respir Med. 2022 Aug;10(8):785-795. doi: 10.1016/S2213-2600(22)00100-X. Epub 2022 Jun 9.
2022
ASL Città di Torino
Ochoa-Azze R; Chang-Monteagudo A; Climent-Ruiz Y; Macías-Abraham C; Valenzuela-Silva C; de Los Ángeles García-García M; Jerez-Barceló Y; Triana-Marrero Y; Ruiz-Villegas L; Dairon Rodríguez-Prieto L; Guerra-Chaviano PP; Sánchez-Ramírez B; Hernández-García T; Orosa-Vázquez I; Díaz-Hernández M; Chiodo F; Calcagno A; Ghisetti V; Rodríguez-Acosta M; Noa-Romero E; Enríquez-Puertas J; Ortega-León D; Valdivia-Álvarez I; Delahanty-Fernández A; Palenzuela-Díaz A; Rodríguez-Noda L; González-Mugica R; Valdés-Balbín Y; García-Rivera D; et alii...
Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition. in Viruses / Viruses. 2022 Apr 4;14(4):753. doi: 10.3390/v14040753.
2022
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Vai D; Nigra M; Imperiale D; Di Stefano A; Atzori C; Pasquero M; Trunfio M;
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. in Journal of neurovirology / J Neurovirol. 2022 Apr;28(2):226-235. doi: 10.1007/s13365-021-01047-y. Epub 2022 Jan 19.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Noce G; Atzori C; Trunfio M; Bonora S; Guastamacchia G; Lazzaro A; Vai D; Pirriatore V; Barco A; Orlando S; Stroffolini G;
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients. in Brain research bulletin / Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.
2022
ASL Città di Torino
Babiloni C; Del Percio C; Lizio R; Lopez S; Pennica A; Roma P; Correr V; Cucciolla F; Toma G; Soricelli A; Di Campli F; Aceti A; Teti E; Sarmati L; Crocetti G; Ferri R; Lorenzo I; Galli M; Negri C; Angarano G; Saracino A; Lepore L; Di Pietro M; Fusco FM; Vullo V; D'Ettorre G; Pagliano P; Di Flumeri G; Celesia BM; et alii...
The importance of Therapeutic Drug Monitoring during pregnancy in a HIV-positive woman taking lifelong antiretroviral therapy in Biochimica Clinica
2022
ASL Città di Torino
Cusato J; D'Avolio A; Di Perri G; Bonora S; Calcagno A; Antonucci M; Marinaro L;
2022
ASL Città di Torino
Guastamacchia G; Bonora S; Di Perri G; Calcagno A; Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants in Pharmaceuticals
2022
ASL Città di Torino
Mula J; Antonucci M; De Nicolò A; Allegra S; De Francia S; Chiara F; Di Perri G; De Rosa FG; Calcagno A; Cusato J; Palermiti A; Manca A; D’avolio A;
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino
Venuti F; Ghisetti V; Longo B; Staffilano E; Alladio F; Trunfio M; Richiardi L; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Lupia T; Bonfanti P; Lapadula G; Barco A; Rossi M; De Benedetto I;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Di Perri G; De Nicolò A; D'Avolio A; Calcagno A; Ianniello A; De Vivo ED; Avataneo V; Cusato J; Mula J; Antonucci M; Manca A; Palermiti A;
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.
2021
ASL Città di Torino
Calcagno A; Tempestilli M; Cusato J; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma. in The American journal of tropical medicine and hygiene / Am J Trop Med Hyg. 2021 Oct 11;105(6):1590-1593. doi: 10.4269/ajtmh.21-0630.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Ribero S; Calcagno A; Senetta R; Fierro MT; Quaglino P; Caracciolo D; Rubatto M; Merli M; Agostini A; Mastorino L; Avallone G; Trunfio M;
Alzheimer Dementia in People Living With HIV. in Neurology. Clinical practice / Neurol Clin Pract. 2021 Oct;11(5):e627-e633. doi: 10.1212/CPJ.0000000000001060.
2021
ASL Città di Torino
Gisslen M; Di Perri G; Guaraldi G; Arena V; d'Ettorre G; Imperiale D; Atzori C; Orofino G; Trunfio M; Celani L; Calcagno A;
Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend. in Life (Basel, Switzerland) / Life (Basel). 2021 Nov 27;11(12):1310. doi: 10.3390/life11121310.
2021
ASL Città di Torino
ASL Asti
Stroffolini G; Calcagno A; Di Perri G; De Rosa FG; Rossi L; Zanet S; Tomassone L; Lupia T; Faraoni S; Segala FV;
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers. in Vaccines / Vaccines (Basel). 2021 Nov 23;9(12):1377. doi: 10.3390/vaccines9121377.
2021
ASL Città di Torino
Bonora S; Calcagno A; Di Perri G; Emanuele T; Burdino E; Ghisetti V; Verga F; Trunfio M;
Low cerebrospinal fluid Amyloid-?eta 1-42 in patients with tuberculous meningitis. in BMC neurology / BMC Neurol. 2021 Nov 16;21(1):449. doi: 10.1186/s12883-021-02468-2.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Trunfio M; Nigra M; Di Stefano A; Guastamacchia G; Atzori C; Audagnotto S; Stroffolini G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino
Di Perri G; Calcagno A; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.
2021
ASL Città di Torino
Focà E; Calcagno A; Milic J; Calza S; Guaraldi G; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Piccioni P; D'Avolio A; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Trentalange A; Motta I; Borgogno E;
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M;
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. in HemaSphere / Hemasphere. 2021 Jun 12;5(7):e592. doi: 10.1097/HS9.0000000000000592. eCollection 2021 Jul.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Cavallo F; Bruno B; Rinaldi M; Cavallo R; Stroffolini G; Zanotto E; Barbero C; Ferrero S; Caracciolo D; Boffini M; Ragaini S; Leone S; Grimaldi D; Calcagno A; Dogliotti I; Clerico M;
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino
Trunfio M; Calcagno A; Bonora S; Di Perri G;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Di Perri G; D'Avolio A; Bonora S; de Nicolò A; Gervasoni C; Mistrangelo M; Testi R; Cattaneo D; Calcagno A; Dal Conte I;
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino
Gervasoni C; Borghetti A; Moltó J; Calcagno A; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. in Viruses / Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.
2021
ASL Città di Torino
Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A;
Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Boglione L; Bonora S; Ghisetti V; Allice T; Trunfio M; Burdino E;
Alzheimer Dementia in People Living With HIV in Neurology: Clinical Practice
2021
ASL Città di Torino
Di Perri G; Trunfio M; Orofino G; Imperiale D; Atzori C; Arena V; D'ettorre G; Guaraldi G; Gisslen M; Calcagno A; Celani L;
Risk for SARS-CoV-2 infection in healthcare workers, Turin, Italy in Emerging Infectious Diseases
2021
ASL Città di Torino
Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G; Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S;
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers in Diagnostics
2021
ASL Città di Torino
Nigra M; Atzori C; Imperiale D; Bonora S; Di Perri G; Calcagno A; Caligaris G; Trunfio M; Ghisetti V; Cusato J;
The use of less neurotoxic antiretrovirals: Secondary endpoints of the Marand-X study in Topics in Antiviral Medicine
2021
ASL Città di Torino
Bonora S; Di Perri G; Mighetto L; Marinaro L; Trunfio M; Noce G; Atzori C; Guastamacchia G; Stroffolini G; Barco A; Orlando S; Pirriatore V; Calcagno A;
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort. in PloS one / PLoS One. 2021 Oct 13;16(10):e0258533. doi: 10.1371/journal.pone.0258533. eCollection 2021.
2021
ASL Città di Torino
Renzetti S; Calza S; Calcagno A; Focà E; Chiesa A; Siano M; De Socio G; Piconi S; Orofino G; Madeddu G; Cattelan AM; Nozza S; Ferrara M; Milic J; Celesia BM; Castelli F; Guaraldi G;
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino
Longo BM; Trunfio M; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV in Expert Opinion on Drug Metabolism and Toxicology
2021
ASL Città di Torino
Trunfio M; Calcagno A; D’Avolio A; Di Perri G; Bonora S;
Low tenofovir plasma exposure in HIV oral pre-exposure prophylaxis recipients with gastrointestinal disorders in Antimicrobial Agents and Chemotherapy
2021
ASL Città di Torino
D'Avolio A; Di Perri G; Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S;
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.
2020
ASL Città di Torino
Calcagno A; Pinnetti C; Mastrangelo A; Bruzzesi E; De Benedetto I; Nozza S; Fabbiani M; Taramasso L; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs. in Journal of neurovirology / J Neurovirol. 2020 Oct;26(5):642-651. doi: 10.1007/s13365-020-00874-9. Epub 2020 Jul 31.
2020
ASL Città di Torino
Calcagno A; Bonora S; Guastamacchia G; De Benedetto I; Trunfio M;
A tinea immune reconstitution inflammatory syndrome in a HIV-positive patient starting combination antiretroviral treatment. in Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia / G Ital Dermatol Venereol. 2020 Oct;155(5):695-697. doi: 10.23736/S0392-0488.18.06097-2. Epub 2019 Ja
2020
ASL Città di Torino
Lupia T; Costa C; Forni N; Calcagno A;
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Guastamacchia G; Vai D; Atzori C; Trunfio M; Borgogno E; Domini S; Nigra M; Mighetto L; Rugge W;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Gianella S; Mighetto L; Imperiale D; Audagnotto S; Milia MG; Atzori C; Lupia T;
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2020 Mar;92:62-68. doi: 10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27.
2020
ASL Città di Torino
Cuzzi G; Compagno M; Cimaglia C; Petruccioli E; Navarra A; Goletti D; De Carli G; Fondaco L; Franzetti F; Giannetti A; Gori A; Lapadula G; Lichtner M; Mastroianni CM; Mazzotta V; Orchi N; Pavone P; Piacentini D; Pirriatore V; Pontali E; Sarmati L; Spolti A; Tacconelli E; Galli M; Antinori A; Calcagno A; Girardi E;
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study. in The Journal of infectious diseases / J Infect Dis. 2020 Jun 29;222(2):263-272. doi: 10.1093/infdis/jiaa088.
2020
ASL Città di Torino
Castelnuovo B; Di Perri G; Lamorde M; Calcagno A; Cusato J; Kafufu B; Borderi M; Mwaka E; Kasozi W; Scabini S; Kaimal A; Costa C;
JC virus DNA in cerebrospinal fluid: insight into clinical significance. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2020 Jun;97(2):115017. doi: 10.1016/j.diagmicrobio.2020.115017. Epub 202
2020
ASL Città di Torino
Calcagno A; Imperiale D; Trunfio M; Mornese Pinna S;
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. in CNS spectrums / CNS Spectr. 2020 Jun;25(3):402-408. doi: 10.1017/S1092852919000981. Epub 2019 May 27.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Burdino E; Audagnotto S; Mighetto L; Milia MG; Lipani F; Imperiale D; Atzori C; Alcantarini C; Di Stefano A;
Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Barco A; Nunnari G; Imperiale D; Cusato J; Tettoni M; Trentalange A; Prochet A;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Roccatello D; Lipani F; Sciascia S; Trentalange A; Gaviraghi A; Alcantarini C; Marinaro L; Cabodi D; Salvador E; Trunfio M;
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino
Calcagno A; Cusato J; Marinaro L; Avataneo V; Di Perri G; Bonora S;
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation in International Journal of Antimicrobial Agents
2020
ASL Città di Torino
Calcagno A; Di Perri G; Celani L; Bonora S; D'Avolio A; Tettoni M; Lazzaro A; D'Ascenzo F; D'Ettorre G; De Nicolò A; Montrucchio C;
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino
Gaviraghi A; Salvador E; Trunfio M; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;
Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica
2020
ASL Città di Torino
Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. in Pathogens & immunity / Pathog Immun. 2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. eCollection 2020.
2020
ASL Città di Torino
Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; Bandera A; Gori A; Tambussi G; Marchetti G; Rusconi S; Cosco L; Di Biagio A; Torti C; Maurizio Celesia B; Pinnetti C; Calcagno A; Ferrara M; Campus M; Ripamonti D; Quiros-Roldan E; Focà E; Antinori A; Dell'acqua R; Ripa M; De Benedetto I; et alii...
Durability of F/TAF in a large cohort of PLWH seen for care in Italy in Journal of the International AIDS Society
2020
ASL Città di Torino
Antinori A; Gentile I; Loredana S; Cicalini S; D'Arminio Monforte A; Moioli M; Guaraldi G; Orofino G; Vergori A; Cozzi Lepri A; Gianotti N; Calcagno A;
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino
Calcagno A; Zanusso G; Bonora S; Di Perri G; Pirriatore V; Amasio E; Ghisetti V; Cassoni P; Kincer LP; Catera S; Imperiale D; Allice T; Trunfio M; Joseph SB; Bertero L;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.
2019
ASL Città di Torino
Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino
Di Perri G; Bonora S; Taraglio S; Imperiale D; Audagnotto S; Boghi A; Manini C; Trentalange A; Trunfio M; Calcagno A;
Alzheimer's dementia cerebrospinal fluid biomarkers in hivpositive patients on cart in Topics in Antiviral Medicine
2019
ASL Città di Torino
Trunfio M; Martini C; Mighetto L; Vai D; Imperiale D; Bonora S; Di Perri G; Calcagno A;
Antiretrovirals concentrations in the olfactory mucosa of hivpositive patients in Topics in Antiviral Medicine
2019
ASL Città di Torino
Calcagno A; De Nicolò A; Trunfio M; Allice T; Imperiale D; Bartoli C; Ghisetti V; Amasio ME; D'Avolio A; Di Perri G; Bonora S;
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino
Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.
2019
ASL Città di Torino
Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders. in HIV medicine / HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
2018
ASL Città di Torino
Di Perri G; Bonora S; Imperiale D; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy. in Le infezioni in medicina / Infez Med. 2018 Jun 1;26(2):160-163.
2018
ASL Città di Torino
Di Perri G; Calcagno A; Cistaro A; Perna M; Cinnirella G; Ghisetti V; Audagnotto S; Bertucci R; Imperiale D; Pirriatore V; Trunfio M; Scabini S;
Precision medicine for HIV: where are we? in Pharmacogenomics / Pharmacogenomics. 2018 Jan;19(2):145-165. doi: 10.2217/pgs-2017-0123. Epub 2017 Dec 5.
2018
ASL Città di Torino
D'Avolio A; Calcagno A; Nicolò A; Allegra S; Cusato J;
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Feb 1;73(2):546-548. doi: 10.1093/jac/dkx385.
2018
ASL Città di Torino
Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Di Perri G; Imperiale D; Sala A; Ferrara M; Pesci Kincer L; Audagnotto S; Cusato J; Martini C; Romito A; Ghisetti V; Joseph SB; Trunfio M; Calcagno A;
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. in Current HIV/AIDS reports / Curr HIV/AIDS Rep. 2018 Feb;15(1):84-91. doi: 10.1007/s11904-018-0375-2.
2018
ASL Città di Torino
Calcagno A; Barco A; Trunfio M; Bonora S;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. in BMC geriatrics / BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
2018
ASL Città di Torino
Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino
Montrucchio C; Audagnotto S; Lucchini A; Calcagno A; Bigliano P; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;
HIV-RNA in the olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2018
ASL Città di Torino
Trunfio M; Allice T; Bertero L; Imperiale D; Catera S; Pirriatore V; Di Perri G; Amasio ME; Cassoni P; Ghisetti V; Bonora S; Calcagno A;
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169.
2017
ASL Città di Torino
Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino
Di Perri G; Bonora S; Lipani F; Prochet A; Ghisetti V; Audagnotto S; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino
Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):539-544. doi: 10.2459/JCM.0000000000000436.
2017
AOU Città della Salute di Torino
ASL Città di Torino
Mancone M; Ballocca F; Grosso Marra W; Calcagno A; D'Ettorre G; Cannillo M; D'Ascenzo F; Gili S; Orofino G; Marruncheddu L; Lonni E; Cinque A; Vullo F; Ceccarelli G; Vilardi I; Sardella G; Vullo V; Moretti C; Fedele F; Bonora S; Gaita F;
Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S;
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino
Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino
Calcagno A; Cusato J; D'Avolio A; Bonora S;
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino
Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino
Sordella F; Bracchi M; Balbiano R; Caracciolo D; Lucchini A; Calcagno A; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;
Additional screening tests for HIV-associated neurocognitive disorders in Topics in Antiviral Medicine
2017
ASL Città di Torino
Trunfio M; Montrucchio C; Vai D; Imperiale D; Livelli A; Orofino G; Trentalange A; Bonora S; Di Perri G; Calcagno A;
Discordant HIV RNA in olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2017
ASL Città di Torino
Calcagno A; Allice T; Bertero L; Trunfio M; Amasio ME; Imperiale D; Ghisetti V; Di Perri G; Cassoni P; Bonora S;
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino
Di Perri G; Imperiale D; Montrucchio C; Stella ML; Audagnotto S; Vai D; Atzori C; Romito A; Calcagno A; Bonora S;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A;
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. in Antiviral therapy / Antivir Ther. 2016;21(7):633-635. doi: 10.3851/IMP3032. Epub 2016 Feb 9.
2016
ASL Città di Torino
Bonora S; Busolli P; Atzori C; Ghisetti V; Calcagno A; Trentalange A; Imperiale D;
Cerebrospinal fluid and plasma biomarkers in patients with HIV-associated neurocognitive disorders in Journal of the International AIDS Society
2016
ASL Città di Torino
Trunfio M; Vai D; Romito A; Atzori C; Imperiale D; Audagnotto S; Montrucchio C; Scabini S; Cardellino C; Pirriatore V; Di Perri G; Bonora S; Calcagno A;
High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. in Atherosclerosis / Atherosclerosis. 2015 May;240(1):197-204. doi: 10.1016/j.atherosclerosis.2015.03.019. Epub 2015 Mar
2015
ASL Città di Torino
Abbate A; Bonora S; De Marie D; Escaned J; Estrada V; Garabello D; Mancone M; Salera D; Raviola A; Mistretta E; Pianelli M; Cannillo M; Gili S; Barbero U; Veglia S; Montefusco A; Omedè P; Ballocca F; Grossomarra W; Calcagno A; Cerrato E; D'Ascenzo F; Zoccai GB; Moretti C; Gaita F;
Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS in Antiviral Therapy
2015
ASL Città di Torino
Trentalange A; Calcagno A; Raviolo S; Prochet A; Audagnotto S; Ghisetti V; Perri GD; Bonora S;
Cardiovascular disease in HIV patients: from bench to bedside and backwards. in Open heart / Open Heart. 2015 Mar 20;2(1):e000174. doi: 10.1136/openhrt-2014-000174. eCollection 2015.
2015
ASL Città di Torino
Escaned J; Estrada V; DiNicolantonio JJ; Bonora S; Abbate A; Omedè P; Demarie D; Grosso Marra W; Mancone M; Biondi-Zoccai G; D'Ascenzo F; Calcagno A; Cerrato E; Moretti C; Gaita F;
Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino
Di Perri G; Trentalange A; Alberione MC; Audagnotto S; Imperiale D; Ecclesia S; Romito A; Atzori C; Calcagno A; Bonora S;
Prevalence and predictors of blood-brain barrier damage in the HAART era in Journal of NeuroVirology
2014
ASL Città di Torino
Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;
Thrombotic events and plaque progression in HIV-infected patients with ACS: Insights from an international contemporary registry in EuroIntervention
2013
ASL Città di Torino
Cerrato E; D'Ascenzo F; Appleton D; Moretti C; Calcagno A; Abouzaki N; Vetrovec G; Lhermusier T; Das Neves B; Escaned J; Cassese S; Kastrati A; Chinaglia A; Belli R; Capodanno D; Tamburino C; Santilli F; Parruti G; Parodi G; Vignali L; Mancone M; Sardella G; Fedele F; Omedè P; Bonora S; Abbate A; Biondi-Zoccai G; Gaita F;
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Rostagno R; Tettoni MC; Bonasso M; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Tenofovir and emtricitabine CSF-to-plasma ratios correlate to the extent of blood-brain-barrier damage in Infection
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Audagnotto S; Siccardi M; De Requena DG; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism in Pharmacogenetics and Genomics
2010
ASL Città di Torino
Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan W-S; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;